Annual Alpha-1 Conference 2014
Thursday, August 14th 2014 14:43
article thumbnailThe annual Alpha-1 conference will take place this year on Friday, October 24th in the Marino Institute of Education in Dublin. We are delighted to confirm that Mr. John Walsh, CEO of the US Alpha-1 Foundation will be our very special guest speaker. John is an Irish-American with Alpha-1 who co-founded the US Alpha-1...
article thumbnailA dramatic decline in smoking rates has coincided with the introduction of plain-packaging laws in Australia. The daily smoking rate decreased from 15.1 per cent to 12.8 per cent between 2010 and 2013, according to the largest and longest-running national survey on drug statistics. Most people are now 16 before they smoke their...
article thumbnailAn exciting new project has been launched by IPPOSI and UCD in an attempt to solve some of the everyday problems that people with medical conditions encounter.  Are you interested in partnering with a healthcare technology company for one day to find a solution to an issue or dilemma that frustrates people with the same or...
National Rare Disease Plan Launch
Thursday, July 17th 2014 16:01
article thumbnailThe National Rare Disease Plan 2014 - 2018, published this month, outlines proposals for a new clinical care programme specifically for the treatment of rare diseases, which affect an estimated 6 to 8 per cent of people in their lifetime. Illnesses which affect fewer than five people in every 10,000 are considered “rare...
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test. 
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, along with cystic fibrosis, is the commonest genetic lung disease in Ireland. It severely affects more than 12,000 people, with another 170,000 carriers also at risk of lung and liver disease. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
Go to top